BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Traversa Therapeutics, Inc. 

505 Coast Boulevard South
Suite 402
La Jolla  California  92037-4613  U.S.A.
Phone: 858-488-6504 Fax: n/a


SEARCH JOBS










 Company News
Ex-Traversa Therapeutics, Inc. CEO Arrested in Shooting Spree 9/20/2013 11:00:39 AM
Traversa Therapeutics, Inc. and Sanofi-Aventis K.K. Enter into a Research Agreement for the Development of Traversa's RNAi Delivery Technology 3/25/2010 10:30:31 AM
Company Profile for Traversa Therapeutics, Inc. 1/8/2010 9:37:42 AM
Traversa Therapeutics, Inc. Appoints Curt W. Bradshaw, Ph.D. as VP of Research & Development 1/6/2010 12:04:58 PM
Traversa Therapeutics, Inc. Completes Series B Financing; Raises $5 Million 4/2/2009 10:54:50 AM
Traversa Therapeutics, Inc. Announces Appointment of William G. Kaelin, Jr., M.D. and Yitzhak Tor, Ph.D. to the Company’s Scientific Advisory Board 3/24/2009 11:49:43 AM
Traversa Therapeutics, Inc. Announces Appointment of Barry Toyonaga Ph.D. as Senior Vice President, Business Development 4/21/2008 3:06:08 PM
Company Profile for Traversa Therapeutics, Inc. 4/17/2008 3:20:24 PM
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing 2/4/2008 9:19:39 AM